P3 Health Partners (PIIIW) Competitors $0.01 0.00 (0.00%) As of 01:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock PIIIW vs. ACONW, AONC, DHACW, FMS, LFMDP, OTRKP, TALKW, TOIIW, NTRA, and HIMSShould you be buying P3 Health Partners stock or one of its competitors? The main competitors of P3 Health Partners include Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), LifeMD (LFMDP), Ontrak (OTRKP), Talkspace (TALKW), Oncology Institute (TOIIW), Natera (NTRA), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry. P3 Health Partners vs. Its Competitors Aclarion American Oncology Network Digital Health Acquisition Fresenius Medical Care AG & Co. KGaA LifeMD Ontrak Talkspace Oncology Institute Natera Hims & Hers Health Aclarion (NASDAQ:ACONW) and P3 Health Partners (NASDAQ:PIIIW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, valuation, risk, institutional ownership, media sentiment, earnings, analyst recommendations and dividends. Does the media refer more to ACONW or PIIIW? In the previous week, P3 Health Partners had 2 more articles in the media than Aclarion. MarketBeat recorded 2 mentions for P3 Health Partners and 0 mentions for Aclarion. P3 Health Partners' average media sentiment score of 0.25 beat Aclarion's score of 0.00 indicating that P3 Health Partners is being referred to more favorably in the news media. Company Overall Sentiment Aclarion Neutral P3 Health Partners Neutral Which has higher earnings & valuation, ACONW or PIIIW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$62.95KN/AN/AN/AN/AP3 Health Partners$1.46BN/AN/AN/AN/A Is ACONW or PIIIW more profitable? Company Net Margins Return on Equity Return on Assets AclarionN/A N/A N/A P3 Health Partners N/A N/A N/A SummaryP3 Health Partners beats Aclarion on 3 of the 3 factors compared between the two stocks. Get P3 Health Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for PIIIW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PIIIW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PIIIW vs. The Competition Export to ExcelMetricP3 Health PartnersMedical Care Facilities IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$1.48B$5.82B$9.75BDividend YieldN/A4.04%3.84%4.09%P/E RatioN/A6.9431.1425.96Price / SalesN/A14.18475.48122.90Price / CashN/A12.3237.1558.38Price / BookN/A1.919.116.38Net IncomeN/A$58.06M$3.26B$265.56M7 Day PerformanceN/A3.58%1.94%1.81%1 Month PerformanceN/A5.27%4.91%1.14%1 Year PerformanceN/A10.69%31.21%20.98% P3 Health Partners Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PIIIWP3 Health PartnersN/A$0.01flatN/A-55.9%$0.00$1.46B0.00500ACONWAclarionN/A$0.05+8.9%N/A+62.2%$0.00$54.60K0.007Gap UpAONCAmerican Oncology NetworkN/A$12.12+15.4%N/A+246.5%$0.00$1.34B0.001,520Gap DownDHACWDigital Health AcquisitionN/A$0.03-6.3%N/AN/A$0.00N/A0.00N/AFMSFresenius Medical Care AG & Co. KGaA2.8104 of 5 stars$24.82-0.1%$27.80+12.0%+32.8%$0.00$20.63B20.321,384News CoverageShort Interest ↑LFMDPLifeMDN/A$23.27+0.8%N/A+8.9%$0.00$245.56M0.00230Positive NewsOTRKPOntrakN/A$0.02flatN/A-90.1%$0.00$10.84M0.00250Gap UpHigh Trading VolumeTALKWTalkspaceN/A$0.06-9.0%N/A+78.3%$0.00$202.61M0.00500Gap DownTOIIWOncology InstituteN/A$0.13-5.9%N/A+553.3%$0.00$403.15M0.00660Positive NewsGap DownNTRANatera3.4297 of 5 stars$156.40-0.8%$193.87+24.0%+32.8%$21.43B$1.70B-81.754,434Positive NewsHIMSHims & Hers Health2.8187 of 5 stars$46.31-4.2%$39.83-14.0%+164.5%$10.35B$2.01B57.781,637Trending NewsAnalyst DowngradeInsider TradeGap Down Related Companies and Tools Related Companies Aclarion Competitors American Oncology Network Competitors Digital Health Acquisition Competitors Fresenius Medical Care AG & Co. KGaA Competitors LifeMD Competitors Ontrak Competitors Talkspace Competitors Oncology Institute Competitors Natera Competitors Hims & Hers Health Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PIIIW) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share P3 Health Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access